Chemoresection and surgical management in low risk non muscle invasive bladder cancer

http://isrctn.com/ ◽

10.1186/isrctn24855462 ◽

2015 ◽

Author(s):

Steven Penegar

Keyword(s):

Bladder Cancer ◽

Surgical Management ◽

Low Risk ◽

Invasive Bladder Cancer ◽

Muscle Invasive Bladder Cancer ◽

Muscle Invasive

Download Full-text

PD66-04 RESULTS OF CALIBER: A PHASE II RANDOMISED FEASIBILITY TRIAL OF CHEMOABLATION VERSUS SURGICAL MANAGEMENT IN LOW RISK NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC)

The Journal of Urology ◽

10.1016/j.juro.2018.02.3000 ◽

2018 ◽

Vol 199 (4S) ◽

Author(s):

Hugh Mostafid ◽

Joanne Cresswell ◽

Leyshon Griffiths ◽

John Kelly ◽

Allen Knight ◽

...

Keyword(s):

Bladder Cancer ◽

Surgical Management ◽

Phase Ii ◽

Low Risk ◽

Feasibility Trial ◽

Invasive Bladder Cancer ◽

Muscle Invasive Bladder Cancer ◽

Muscle Invasive

Download Full-text

Results of CALIBER: A phase II randomised feasibility trial of chemoablation versus surgical management in low risk non-muscle invasive bladder cancer

European Urology Supplements ◽

10.1016/s1569-9056(18)31571-9 ◽

2018 ◽

Vol 17 (2) ◽

pp. e1062-e1063 ◽

Author(s):

H. Mostafid ◽

J. Cresswell ◽

T. Griffiths ◽

J. Kelly ◽

A. Knight ◽

...

Keyword(s):

Bladder Cancer ◽

Surgical Management ◽

Phase Ii ◽

Low Risk ◽

Feasibility Trial ◽

Invasive Bladder Cancer ◽

Muscle Invasive Bladder Cancer ◽

Muscle Invasive

Download Full-text

CALIBER: a phase II randomized feasibility trial of chemoablation with mitomycin-C vs surgical management in low-risk non-muscle-invasive bladder cancer

BJU International ◽

10.1111/bju.15038 ◽

2020 ◽

Vol 125 (6) ◽

pp. 817-826 ◽

Author(s):

A. Hugh Mostafid ◽

Nuria Porta ◽

Joanne Cresswell ◽

Thomas R.L. Griffiths ◽

John D. Kelly ◽

...

Keyword(s):

Bladder Cancer ◽

Mitomycin C ◽

Surgical Management ◽

Phase Ii ◽

Low Risk ◽

Feasibility Trial ◽

Invasive Bladder Cancer ◽

Muscle Invasive Bladder Cancer ◽

Muscle Invasive

Download Full-text

CALIBER: a phase II randomized feasibility trial of chemoablation with mitomycin‐C vs surgical management in low‐risk non‐muscle‐invasive bladder cancer

BJU International ◽

10.1111/bju.15214 ◽

2020 ◽

Vol 126 (6) ◽

pp. 663-663

Author(s):

Francesco Montorsi ◽

Marco Moschini ◽

Andrea Necchi

Keyword(s):

Bladder Cancer ◽

Mitomycin C ◽

Surgical Management ◽

Phase Ii ◽

Low Risk ◽

Feasibility Trial ◽

Invasive Bladder Cancer ◽

Muscle Invasive Bladder Cancer ◽

Muscle Invasive

Download Full-text

12 month results of CALIBER: A phase II randomised feasibility trial of chemoablation with MMC versus surgical management in low risk (LR) non-muscle invasive bladder cancer (NMIBC)

European Urology Supplements ◽

10.1016/s1569-9056(19)30560-3 ◽

2019 ◽

Vol 18 (1) ◽

pp. e762-e763

Author(s):

H. Mostafid ◽

N. Porta ◽

J. Cresswell ◽

T. Griffiths ◽

J. Kelly ◽

...

Keyword(s):

Bladder Cancer ◽

Surgical Management ◽

Phase Ii ◽

Low Risk ◽

Feasibility Trial ◽

Invasive Bladder Cancer ◽

Muscle Invasive Bladder Cancer ◽

Muscle Invasive

Download Full-text

PD41-07 EXAMINING THE MD ANDERSON RISK CRITERIA FOR PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER: ARE LOW RISK PATIENTS HARMED WITH UPFRONT CYSTECTOMY?

The Journal of Urology ◽

10.1016/j.juro.2018.02.1946 ◽

2018 ◽

Vol 199 (4S) ◽

Author(s):

Timothy Lyon ◽

Igor Frank ◽

Paras Shah ◽

Vidit Sharma ◽

Matthew Tollefson ◽

...

Keyword(s):

Bladder Cancer ◽

Low Risk ◽

Invasive Bladder Cancer ◽

Muscle Invasive Bladder Cancer ◽

Risk Criteria ◽

Risk Patients ◽

Muscle Invasive ◽

Download Full-text

Reduced recurrence of low‐risk non‐muscle‐invasive bladder cancer is associated with low urine‐specific gravity

International Journal of Urology ◽

10.1111/iju.14351 ◽

2020 ◽

Vol 27 (11) ◽

pp. 1019-1023

Author(s):

Tomohiro Iwasawa ◽

Naoya Niwa ◽

Kazuhiro Matsumoto ◽

Akari Komatsuda ◽

Hiroki ide ◽

...

Keyword(s):

Bladder Cancer ◽

Specific Gravity ◽

Low Risk ◽

Invasive Bladder Cancer ◽

Urine Specific Gravity ◽

Muscle Invasive Bladder Cancer ◽

Muscle Invasive

Download Full-text

Discharge of low risk non muscle invasive bladder cancer after one year: Results of a national survey of the adoption of the NICE bladder cancer guidelines recommendations in the UK

European Urology Supplements ◽

10.1016/s1569-9056(18)31576-8 ◽

2018 ◽

Vol 17 (2) ◽

pp. e1068 ◽

Author(s):

H. Mostafid ◽

S. Malde ◽

A. Mir-Kohler ◽

P. Bagnall ◽

J. Taylor ◽

...

Keyword(s):

Bladder Cancer ◽

National Survey ◽

Low Risk ◽

Invasive Bladder Cancer ◽

Muscle Invasive Bladder Cancer ◽

Cancer Guidelines ◽

Muscle Invasive ◽

One Year ◽

Download Full-text

Should we spare neoadjuvant chemotherapy in low-risk muscle-invasive bladder cancer patients scheduled for radical cystectomy?

Translational Andrology and Urology ◽

10.21037/tau.2019.04.04 ◽

2019 ◽

Vol 8 (S3) ◽

pp. S283-S286

Author(s):

Günter Niegisch

Keyword(s):

Bladder Cancer ◽

Neoadjuvant Chemotherapy ◽

Cancer Patients ◽

Radical Cystectomy ◽

Low Risk ◽

Invasive Bladder Cancer ◽

Muscle Invasive Bladder Cancer ◽

Muscle Invasive

Download Full-text

Oncological long-term safety and pathological outcome evaluation for patients under active surveillance for recurrent low-risk non-muscle invasive bladder cancer: Result from bladder cancer Italian active surveillance (BIAS) project

European Urology Open Science ◽

10.1016/s2666-1683(20)33371-1 ◽

2020 ◽

Vol 19 ◽

pp. e1172

Author(s):

N. Frego ◽

P. Diana ◽

D. Maffei ◽

F. Regis ◽

M. Paciotti ◽

...

Keyword(s):

Bladder Cancer ◽

Active Surveillance ◽

Outcome Evaluation ◽

Low Risk ◽

Invasive Bladder Cancer ◽

Muscle Invasive Bladder Cancer ◽

Muscle Invasive

Download Full-text